The global chemotherapy induced anemia market was valued at $2.7 billion in 2022, and is projected to reach $5.0 billion by 2032, growing at a CAGR of 6.3% from 2023 to 2032.
Report Code : A10539 | Pages : 249 | Category : Life Sciences
The global chemotherapy induced peripheral neuropathy treatment market was valued at $0.9 billion in 2023, and is projected to reach $1.6 billion by 2033, growing at a CAGR of 6.1% from 2024 to 2033.
Report Code : A324389 | Pages : 280 | Category : Life Sciences
The global cancer therapeutics market size was valued at $98,900 million in 2018 and is estimated to reach at $180,193 million by 2026, registering a CAGR of 7.7% from 2019 to 2026. Cancer therapeutics involves the use and administration of chemotherapy and oncology drugs to treat cancer.
Report Code : A00381 | Pages : 261 | Category : Life Sciences
The China oncology drugs market was valued at $6,498.2 million in 2018 and is projected to reach $12,688.7 million by 2026, registering a CAGR of 8.7% from 2019 ...
Report Code : A04505 | Pages : 135 | Category : Life Sciences
The Japan oncology drugs market size was accounted for $9,405 million in 2018, and is expected to reach $14,109 million by 2026, registering a CAGR of 5.2% from 2019 to 2026.
Report Code : A05277 | Pages : 147 | Category : Life Sciences
The global prostate cancer treatment market size was valued at $6,887 million in 2018, and is projected to reach $9,904 million by 2026, registering a CAGR of 4.6% from 2019 to 2026.
Report Code : A02321 | Pages : 188 | Category : Life Sciences
Antibody Drug Conjugates Market are highly effective biopharmaceutical medications designed as a targeted therapy for cancer treatment. ADC™s are designed to eliminate cancer cells only without harming the ...
Report Code : A01148 | Pages : 152 | Category : Life Sciences
The global liver disease treatment market size was valued at $20,673.70 million in 2020, and is estimated to reach $36,455.70 million by 2030, growing at a CAGR of ...
Report Code : A00295 | Pages : 254 | Category : Life Sciences
The global cancer immunotherapy market size was valued at $85,603.50 million in 2020, and is projected to reach $309,667.65 million by 2030, registering a CAGR of 14.1% from 2021 to 2030.
Report Code : A01913 | Pages : 207 | Category : Life Sciences
The top 10 cancer drugs market size was valued at $77.9 billion in 2022 and is estimated to reach $198.8 billion by 2032, exhibiting a CAGR of 10.0% ...
Report Code : A05860 | Pages : 190 | Category : Life Sciences
Castration-Resistant Prostate Cancer (CRPC) or Hormone Refractory Prostate Cancer (CRPC), a type of prostate cancer that typically recurs after administering androgen deprivation therapy (ADT), is gaining prominence in ...
Report Code : A00568 | Pages : 122 | Category : Life Sciences
Global filgrastim market was valued at $ 562.50 million in 2020 and is projected to reach $745.90 million by 2030 registering a CAGR of 2.80% from 2021 to 2030.
Report Code : A03303 | Pages : 193 | Category : Life Sciences
The global UV infection control devices market size was valued at $317.42 million in 2018, and is projected to reach $524.84 million by 2026, registering a CAGR of 6.5% from 2019 to 2026.
Report Code : A06107 | Pages : 154 | Category : Life Sciences
The global cancer vaccines market was valued at $4,188 million in 2019, and is projected to reach $7,303 million by 2027, registering a CAGR of 12.6% from 2020 to 2027.
Report Code : A01134 | Pages : 284 | Category : Life Sciences
The global veterinary oncology market size was valued at $297.30 million in 2020, and is estimated to reach $819.84 million by 2030, growing at a CAGR of 10.8% from 2021 to 2030.
Report Code : A07139 | Pages : 257 | Category : Life Sciences
The global oncology-cancer drugs market was valued at $167.0 billion in 2023, and is projected to reach $335.2 billion by 2033, growing at a CAGR of 7.2% from 2024 to 2033.
Report Code : A00042 | Pages : 250 | Category : Life Sciences
The global intravenous equipment market was valued at $15.0 billion in 2022, and is projected to reach $26.7 billion by 2032, growing at a CAGR of 5.9% from 2023 to 2032.
Report Code : A10856 | Pages : 250 | Category : Life Sciences
Cancer in pets can be of many forms such as soft tissue sarcomas and mast cell tumors, which potentially can be cured or restricted from spreading further with ...
Report Code : A10911 | Category : Life Sciences
The global breast cancer drugs market was valued at $26.4 billion in 2022, and is projected to reach $59.3 billion by 2032, growing at a CAGR of 8.4% from 2023 to 2032.
Report Code : A11123 | Pages : 252 | Category : Life Sciences
The global medical foods market is experiencing a major growth, and will grow considerably in next few years. Medical foods are specially framed and processed foods for dietary ...
Report Code : A11184 | Category : Life Sciences
The global compounding chemotherapy market was valued at $5.3 billion in 2024, and is projected to reach $9.8 billion by 2034, growing at a CAGR of 6.4% from 2025 to 2034.
Report Code : A11418 | Pages : 364 | Category : Life Sciences
Granisetron is a serotonin 5-HT3 receptor antagonist used as an antiemetic to treat nausea and vomiting following chemotherapy and radiotherapy. Its major effect is to reduce the activity ...
Report Code : A12478 | Category : Life Sciences
Folliculotropic mycosis fungoides is a type of cutaneous T-cell lymphoma. This is a rare disease in which white blood cells (WBC) turn into cancerous cell due genetic mutation. ...
Report Code : A13192 | Category : Life Sciences
The global head & neck cancer drugs market was valued at $1,295 million in 2017, and is projected to reach $2,281 million by 2025, registering a CAGR of 7.3% from 2018 to 2025.
Report Code : A04812 | Pages : 201 | Category : Life Sciences
3D Printed Drugs Market are medications, which are designed by 3D printing technique to customize for the individuals in a safer and effective way. These drugs have unitary ...
Report Code : A04158 | Pages : 125 | Category : Life Sciences
